I am a Clinical Lecturer at Imperial College, London and the George Institue for Global Health and a Locum Consultant in Obstetrics and Gynaecology at Queen Charlotte’s and Chelsea Hospital, London.
I am dedicated to improving lifecourse health for women and their children. To achieve this I am developing research projects to combine public health and obstetric care, focussing on preconception and postnatal interventions. I aim to deliver accessible programs for effective lifestyle change to allow women to gain the best possible health before and after pregnancy to reduce their and their children's lifetime risks of obesity, diabetes and cardiovascular disease.
During clinical training I have completed my PhD at Imperial College investigating Fetal Growth Restriction and won a Health Education England-funded fellowship with Professor Dame Sally Davies at the UK Department of Health. As Editor-in-Chief of the Chief Medical Officer's Annual Report, 'The Health of the 51%: Women', published in 2015, I worked with experts from across women's health in the UK to deliver a report which has contributed to numerous improvements in policy and practice.
My invited roles include clinical advisor to Professor Chris Whitty, DHSC; Policy advisor to the Royal College of Obstetricians and Gynaecologists, membership of Public Health England’s Reproductive Health Consensus working group and chapter author for, 'Women's Health', in Kumar and Clark's textbook of clinical medicine.
My response to COVID-19 has included
-co-PI for PAN-COVID study, https://pan-covid.org/, NIHR-funded global registry of women affected by suspected COVID-19 or confirmed SARS-CoV-2 infection in pregnancy and their neonates
-co-PI for COM-SARS-2 study, historical seroprevalence study in 11,000 maternal serum samples to evaluate community transmission of SARs-CoV-2 in NW London
-Rapid reviews of impact of coronavirus infection on women in pregnancy and children
-Maternity service change to introduce post-delivery contraception in NW London, to allow women to access reliable family planning before discharge from their maternity service
- Impact of COVID-19 on pregnancy and neonates
- Prevention of gestational diabetes
- Prevention of T2DM in women
- Prevention of hypertension in pregnancy
- Management of fetal growth restriction
- Post-delivery contraception - Zoom Conference December 16th, 2020 -details to follow.
Laycock HC, Mullins E, 2021, The role of anaesthetists in women's health, Anaesthesia, Vol:76, ISSN:0003-2409, Pages:3-5
et al., 2021, Pregnancy and neonatal outcomes of COVID-19: co-reporting of common outcomes from PAN-COVID and AAP SONPM registries, Ultrasound in Obstetrics and Gynecology, Vol:57, ISSN:0960-7692, Pages:5733-581
et al., 2021, Pregnancy and Neonatal Outcomes in COVID-19: Study protocol for a global registry of women with suspected or confirmed SARS-CoV-2 infection in pregnancy and their neonates, understanding natural history to guide treatment and prevention, Bmj Open, Vol:11, ISSN:2044-6055, Pages:1-6
et al., 2021, Pregnancy and neonatal outcomes of COVID-19 – co-reporting of common outcomes from the PAN-COVID and AAP SONPM registry
et al., 2020, SARS-CoV-2 (COVID-19): What do we know about children? A systematic review., Clinical Infectious Diseases, Vol:71, ISSN:1058-4838, Pages:2469-2479